Mutations in p53 are the most prevalent genetic alterations in human cancers, with the majority mapping to its DNA-binding domain, underscoring the pivotal role of p53’s transcriptional activity in tumor suppression [32,33]. The gene discussed is TP53; the disease is neoplasm.